Reduction of Artificial Tears and Use of Adjunctive Dry Eye Therapies After Lifitegrast Treatment: Evidence from Clinical and Real-World Studies.
Kelly K NicholsEric D DonnenfeldCharis LauAnnie SyntosiPaul M KarpeckiJohn A HovanesianPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
The findings show that the reliance on AT use can be gradually reduced with lifitegrast treatment, eventually leading to a reduction in disease burden.